Aarkstore Enterprise Small-Cell Lung Cancer - Pipeline Review, Q1 2011

March 2, 2011 - PRLog -- Aarkstore announce a new report  "Small-Cell Lung Cancer - Pipeline Review, Q1 2011" through its vast collection of market research report.

Summary

Small-Cell Lung Cancer - Pipeline Review, Q1 2011, provides an overview of the Small-Cell Lung Cancer therapeutic pipeline. This report provides information on the therapeutic development for Small-Cell Lung Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Small-Cell Lung Cancer. Small-Cell Lung Cancer - Pipeline Review, Q1 2011 is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by team.

Scope

- A snapshot of the global therapeutic scenario for Small-Cell Lung Cancer.
- A review of the Small-Cell Lung Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Small-Cell Lung Cancer pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Small-Cell Lung Cancer.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Small-Cell Lung Cancer pipeline depth and focus of Small-Cell Lung Cancer therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

For more information, please visit:
http://www.aarkstore.com/reports/Small-Cell-Lung-Cancer-P...
Or email us at press@aarkstore.com or call +919272852585

Related Reports

Small-Cell Lung Cancer (SCLC) Clinical Trials Review, Q4 2010
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report
Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report

Aarkstore Enterprise
Tel : +912227453309
Mobile No:+919272852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Blog: http://www.emarketreports.com
Follow us on twitter: http://twitter.com/aarkstoredotcom

# # #

Aarkstore Enterprise specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.